| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis, Inclusion Body | 44 | 2023 | 146 | 16.680 |
Why?
|
| Myositis | 18 | 2023 | 241 | 4.770 |
Why?
|
| Dermatomyositis | 19 | 2022 | 217 | 4.760 |
Why?
|
| Interferon Type I | 15 | 2022 | 519 | 2.850 |
Why?
|
| Muscle, Skeletal | 38 | 2023 | 4951 | 2.510 |
Why?
|
| Polymyositis | 10 | 2013 | 76 | 2.420 |
Why?
|
| Muscle Fibers, Skeletal | 8 | 2020 | 563 | 1.850 |
Why?
|
| 5'-Nucleotidase | 6 | 2020 | 153 | 1.830 |
Why?
|
| Interferon-beta | 8 | 2017 | 320 | 1.630 |
Why?
|
| Lectins, C-Type | 5 | 2022 | 588 | 0.980 |
Why?
|
| Neuromuscular Diseases | 6 | 2014 | 257 | 0.940 |
Why?
|
| Autoantibodies | 8 | 2020 | 2002 | 0.890 |
Why?
|
| Receptors, Immunologic | 6 | 2022 | 1417 | 0.870 |
Why?
|
| Muscle Proteins | 6 | 2011 | 1167 | 0.870 |
Why?
|
| Lichen Planus, Oral | 1 | 2022 | 45 | 0.860 |
Why?
|
| Muscle Weakness | 6 | 2013 | 405 | 0.860 |
Why?
|
| Scapula | 2 | 2013 | 154 | 0.820 |
Why?
|
| Guillain-Barre Syndrome | 3 | 2014 | 135 | 0.800 |
Why?
|
| Autoimmune Diseases | 4 | 2023 | 2069 | 0.770 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 2 | 2020 | 23 | 0.760 |
Why?
|
| Interferon-alpha | 8 | 2013 | 894 | 0.670 |
Why?
|
| Cytokines | 8 | 2019 | 7180 | 0.670 |
Why?
|
| Myasthenia Gravis | 2 | 2015 | 193 | 0.640 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2022 | 1825 | 0.620 |
Why?
|
| Follistatin | 1 | 2017 | 141 | 0.580 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 16 | 2012 | 3965 | 0.580 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2014 | 162 | 0.550 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2015 | 8 | 0.540 |
Why?
|
| Cell Nucleus | 5 | 2014 | 3007 | 0.520 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2013 | 61 | 0.520 |
Why?
|
| Ubiquitins | 3 | 2013 | 380 | 0.510 |
Why?
|
| Motor Neuron Disease | 1 | 2015 | 107 | 0.500 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2014 | 158 | 0.500 |
Why?
|
| Nitrous Oxide | 1 | 2015 | 176 | 0.490 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2015 | 115 | 0.490 |
Why?
|
| Autoantigens | 4 | 2013 | 885 | 0.480 |
Why?
|
| Median Nerve | 1 | 2014 | 129 | 0.480 |
Why?
|
| Vitamin B 12 | 2 | 2015 | 521 | 0.470 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4308 | 0.470 |
Why?
|
| Publication Bias | 2 | 2011 | 155 | 0.460 |
Why?
|
| Zinc | 2 | 2010 | 682 | 0.460 |
Why?
|
| Muscles | 2 | 2016 | 1602 | 0.440 |
Why?
|
| Plasma Cells | 4 | 2014 | 587 | 0.440 |
Why?
|
| Humans | 105 | 2023 | 725187 | 0.430 |
Why?
|
| Muscular Diseases | 5 | 2010 | 570 | 0.430 |
Why?
|
| Ataxia | 1 | 2014 | 294 | 0.430 |
Why?
|
| Dendritic Cells | 5 | 2012 | 2682 | 0.430 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2014 | 290 | 0.430 |
Why?
|
| Isoantibodies | 1 | 2016 | 678 | 0.420 |
Why?
|
| Myokymia | 1 | 2011 | 12 | 0.420 |
Why?
|
| Fasciitis | 1 | 2012 | 63 | 0.410 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 378 | 0.400 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2011 | 37 | 0.400 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 384 | 0.400 |
Why?
|
| Movement Disorders | 1 | 2014 | 430 | 0.390 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2010 | 38 | 0.390 |
Why?
|
| Vacuoles | 2 | 2013 | 232 | 0.390 |
Why?
|
| Gene Expression Profiling | 13 | 2012 | 9379 | 0.390 |
Why?
|
| Proteomics | 4 | 2012 | 3447 | 0.380 |
Why?
|
| Up-Regulation | 6 | 2019 | 4234 | 0.380 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2005 | 612 | 0.370 |
Why?
|
| Gene Expression | 7 | 2014 | 7819 | 0.360 |
Why?
|
| Muscle Cells | 2 | 2012 | 195 | 0.360 |
Why?
|
| Sarcomeres | 2 | 2009 | 368 | 0.360 |
Why?
|
| Scleroderma, Systemic | 4 | 2014 | 297 | 0.360 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2009 | 72 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 5 | 2014 | 9245 | 0.350 |
Why?
|
| Immunologic Factors | 4 | 2020 | 1543 | 0.340 |
Why?
|
| T-Lymphocytes | 6 | 2020 | 10007 | 0.340 |
Why?
|
| Autoimmunity | 3 | 2013 | 1320 | 0.330 |
Why?
|
| Nervous System Diseases | 3 | 2004 | 1620 | 0.330 |
Why?
|
| Antibodies, Neoplasm | 1 | 2009 | 292 | 0.320 |
Why?
|
| Enzymes | 1 | 2009 | 265 | 0.310 |
Why?
|
| Skin | 4 | 2010 | 4313 | 0.300 |
Why?
|
| Gadolinium DTPA | 1 | 2010 | 831 | 0.300 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2007 | 46 | 0.300 |
Why?
|
| Microarray Analysis | 2 | 2014 | 768 | 0.290 |
Why?
|
| Transcriptional Activation | 2 | 2010 | 1821 | 0.290 |
Why?
|
| Microdissection | 4 | 2010 | 153 | 0.290 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2009 | 1105 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2007 | 377 | 0.280 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11507 | 0.270 |
Why?
|
| Neurology | 2 | 2004 | 751 | 0.270 |
Why?
|
| Inclusion Bodies | 3 | 2019 | 277 | 0.270 |
Why?
|
| Polyradiculoneuropathy | 2 | 2002 | 66 | 0.260 |
Why?
|
| Antigens, CD | 1 | 2016 | 4052 | 0.260 |
Why?
|
| Immunohistochemistry | 8 | 2014 | 11484 | 0.260 |
Why?
|
| Models, Immunological | 1 | 2007 | 530 | 0.260 |
Why?
|
| Ventilator Weaning | 1 | 2006 | 147 | 0.260 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2014 | 36 | 0.240 |
Why?
|
| B-Lymphocytes | 4 | 2011 | 4738 | 0.240 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2014 | 1559 | 0.240 |
Why?
|
| Meningioma | 1 | 2012 | 1182 | 0.230 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 843 | 0.230 |
Why?
|
| Polymers | 1 | 2010 | 1627 | 0.230 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 9716 | 0.230 |
Why?
|
| GTP-Binding Proteins | 4 | 2010 | 977 | 0.230 |
Why?
|
| Ultrasonography | 2 | 2021 | 5891 | 0.220 |
Why?
|
| Thymoma | 1 | 2004 | 185 | 0.220 |
Why?
|
| RNA, Messenger | 8 | 2017 | 13044 | 0.210 |
Why?
|
| Male | 38 | 2019 | 347096 | 0.210 |
Why?
|
| Immunity, Innate | 1 | 2014 | 2934 | 0.210 |
Why?
|
| Biopsy | 8 | 2012 | 6728 | 0.210 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2001 | 24 | 0.210 |
Why?
|
| Myeloid Cells | 1 | 2007 | 795 | 0.210 |
Why?
|
| Publishing | 1 | 2009 | 824 | 0.210 |
Why?
|
| Cytosol | 2 | 2017 | 916 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 1969 | 0.210 |
Why?
|
| Signal Transduction | 7 | 2022 | 23448 | 0.200 |
Why?
|
| Thymus Neoplasms | 1 | 2004 | 268 | 0.200 |
Why?
|
| Copper | 1 | 2004 | 369 | 0.200 |
Why?
|
| Electromyography | 4 | 2016 | 1373 | 0.200 |
Why?
|
| Middle Aged | 28 | 2019 | 212292 | 0.200 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 267 | 0.190 |
Why?
|
| Myoblasts | 1 | 2022 | 247 | 0.190 |
Why?
|
| Nervous System | 1 | 2004 | 560 | 0.190 |
Why?
|
| tau Proteins | 1 | 2009 | 1750 | 0.180 |
Why?
|
| Hematologic Diseases | 1 | 2004 | 493 | 0.180 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2010 | 108 | 0.180 |
Why?
|
| Data Collection | 1 | 2009 | 3321 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2022 | 34776 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 2 | 2009 | 3388 | 0.170 |
Why?
|
| Mass Spectrometry | 3 | 2013 | 2222 | 0.170 |
Why?
|
| Gene Expression Regulation | 9 | 2012 | 12180 | 0.170 |
Why?
|
| Aged | 20 | 2018 | 161486 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2014 | 2569 | 0.170 |
Why?
|
| Sjogren's Syndrome | 1 | 2020 | 229 | 0.160 |
Why?
|
| Female | 34 | 2020 | 375449 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1167 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2012 | 3023 | 0.150 |
Why?
|
| Immunoglobulins | 3 | 2014 | 897 | 0.150 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 1996 | 22 | 0.150 |
Why?
|
| Larynx | 1 | 2021 | 476 | 0.150 |
Why?
|
| Immunoblotting | 2 | 2011 | 1728 | 0.150 |
Why?
|
| Adult | 29 | 2020 | 211615 | 0.150 |
Why?
|
| Arsenic Poisoning | 1 | 1996 | 54 | 0.150 |
Why?
|
| South Australia | 1 | 2016 | 19 | 0.150 |
Why?
|
| Neural Conduction | 2 | 2011 | 475 | 0.140 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2007 | 330 | 0.140 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 304 | 0.140 |
Why?
|
| Myelin Proteins | 1 | 1996 | 218 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3467 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 4122 | 0.140 |
Why?
|
| Trachea | 1 | 2021 | 1077 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3877 | 0.130 |
Why?
|
| Databases, Genetic | 3 | 2010 | 1784 | 0.130 |
Why?
|
| Lymphocytosis | 1 | 2016 | 117 | 0.130 |
Why?
|
| Chromatography, Liquid | 2 | 2009 | 975 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2011 | 3277 | 0.130 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 1996 | 701 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2007 | 5913 | 0.130 |
Why?
|
| Neoplasms | 1 | 2023 | 20941 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 12935 | 0.130 |
Why?
|
| Smad2 Protein | 1 | 2014 | 159 | 0.130 |
Why?
|
| Smad3 Protein | 1 | 2014 | 183 | 0.120 |
Why?
|
| Demyelinating Diseases | 1 | 1996 | 364 | 0.120 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 250 | 0.120 |
Why?
|
| Activin Receptors, Type II | 1 | 2014 | 118 | 0.120 |
Why?
|
| B-Cell Maturation Antigen | 2 | 2014 | 109 | 0.120 |
Why?
|
| Immune System | 2 | 2010 | 790 | 0.120 |
Why?
|
| Myofibrils | 1 | 2014 | 151 | 0.120 |
Why?
|
| Immunosuppressive Agents | 3 | 2017 | 4105 | 0.120 |
Why?
|
| Thigh | 1 | 2014 | 244 | 0.120 |
Why?
|
| Research Design | 1 | 2009 | 5930 | 0.120 |
Why?
|
| Myopathies, Nemaline | 2 | 2004 | 75 | 0.120 |
Why?
|
| Myelitis, Transverse | 1 | 2013 | 39 | 0.120 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 8657 | 0.110 |
Why?
|
| Osteitis Deformans | 1 | 2013 | 52 | 0.110 |
Why?
|
| Down-Regulation | 3 | 2012 | 3024 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2010 | 1271 | 0.110 |
Why?
|
| Critical Care | 1 | 2006 | 2580 | 0.110 |
Why?
|
| Creatine Kinase | 2 | 2012 | 692 | 0.110 |
Why?
|
| Glycolysis | 2 | 2009 | 820 | 0.110 |
Why?
|
| Molecular Weight | 1 | 2014 | 2327 | 0.110 |
Why?
|
| Epitope Mapping | 1 | 2013 | 312 | 0.110 |
Why?
|
| Antigens, Surface | 2 | 2007 | 1684 | 0.100 |
Why?
|
| Homocysteine | 1 | 2015 | 642 | 0.100 |
Why?
|
| Prions | 1 | 2013 | 176 | 0.100 |
Why?
|
| Point Mutation | 1 | 1996 | 1633 | 0.100 |
Why?
|
| History, 19th Century | 2 | 2004 | 723 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 498 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2014 | 8487 | 0.100 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 337 | 0.100 |
Why?
|
| Neuromuscular Agents | 1 | 2012 | 136 | 0.100 |
Why?
|
| Chelation Therapy | 1 | 2010 | 67 | 0.100 |
Why?
|
| Membrane Glycoproteins | 3 | 2007 | 3785 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4799 | 0.090 |
Why?
|
| B-Cell Activating Factor | 1 | 2010 | 119 | 0.090 |
Why?
|
| Frontotemporal Dementia | 1 | 2013 | 224 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 922 | 0.090 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.090 |
Why?
|
| Animals | 12 | 2019 | 168714 | 0.090 |
Why?
|
| Congo Red | 1 | 2009 | 46 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 1805 | 0.090 |
Why?
|
| Organ Size | 1 | 2014 | 2259 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7921 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2001 | 1876 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 283 | 0.090 |
Why?
|
| Autocrine Communication | 1 | 2010 | 173 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 459 | 0.090 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 151 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 17354 | 0.080 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 211 | 0.080 |
Why?
|
| Choristoma | 1 | 2010 | 214 | 0.080 |
Why?
|
| Calpain | 1 | 2009 | 149 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2019 | 19485 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2010 | 724 | 0.080 |
Why?
|
| Syndecan-1 | 2 | 2007 | 164 | 0.080 |
Why?
|
| Actinin | 1 | 2009 | 163 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 24031 | 0.080 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 183 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2011 | 2075 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4875 | 0.080 |
Why?
|
| Cell Count | 2 | 2010 | 1871 | 0.080 |
Why?
|
| Germinal Center | 1 | 2010 | 372 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2012 | 2761 | 0.080 |
Why?
|
| RecQ Helicases | 1 | 2007 | 60 | 0.080 |
Why?
|
| Leukocytes | 2 | 2013 | 2057 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2009 | 842 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2019 | 39918 | 0.080 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 409 | 0.080 |
Why?
|
| Solubility | 1 | 2009 | 1102 | 0.080 |
Why?
|
| Mutation | 3 | 2013 | 29672 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 412 | 0.080 |
Why?
|
| Neurofilament Proteins | 1 | 2009 | 315 | 0.080 |
Why?
|
| Biological Assay | 1 | 2010 | 660 | 0.080 |
Why?
|
| Antibody Specificity | 1 | 2009 | 1108 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2007 | 2519 | 0.080 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2007 | 46 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2009 | 380 | 0.080 |
Why?
|
| DNA Probes | 2 | 2005 | 560 | 0.080 |
Why?
|
| Exercise Test | 1 | 2014 | 2043 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 443 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 7814 | 0.070 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 59 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2021 | 51869 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 511 | 0.070 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 324 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3489 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1850 | 0.070 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 186 | 0.070 |
Why?
|
| Endopeptidases | 1 | 2010 | 773 | 0.070 |
Why?
|
| Video Recording | 1 | 2011 | 932 | 0.070 |
Why?
|
| Syndecans | 1 | 2005 | 79 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4501 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2014 | 57656 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 187 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 180 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2004 | 2740 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2007 | 252 | 0.070 |
Why?
|
| Lasers | 1 | 2010 | 941 | 0.070 |
Why?
|
| Dystrophin | 1 | 2006 | 283 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 15442 | 0.070 |
Why?
|
| Rheumatic Diseases | 1 | 2011 | 556 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1717 | 0.070 |
Why?
|
| Atrophy | 1 | 2009 | 1514 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 684 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2010 | 2022 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 965 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2004 | 1812 | 0.060 |
Why?
|
| Amyloid | 1 | 2009 | 754 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2018 | 3174 | 0.060 |
Why?
|
| Genome | 1 | 2013 | 1801 | 0.060 |
Why?
|
| London | 1 | 2004 | 236 | 0.060 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2004 | 118 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2012 | 1239 | 0.060 |
Why?
|
| Ceruloplasmin | 1 | 2004 | 54 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2020 | 651 | 0.060 |
Why?
|
| Pedigree | 1 | 2012 | 4647 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 557 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2014 | 11883 | 0.060 |
Why?
|
| Liver | 1 | 2019 | 7494 | 0.060 |
Why?
|
| Proteins | 2 | 2010 | 6088 | 0.060 |
Why?
|
| Vital Capacity | 1 | 2006 | 910 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2007 | 581 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 2801 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 946 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 38748 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2010 | 1635 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 1389 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2005 | 838 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2007 | 719 | 0.050 |
Why?
|
| Genomics | 2 | 2012 | 5565 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2006 | 401 | 0.050 |
Why?
|
| Kinetics | 1 | 2010 | 6554 | 0.050 |
Why?
|
| Alopecia Areata | 1 | 2004 | 104 | 0.050 |
Why?
|
| Artifacts | 1 | 2010 | 1891 | 0.050 |
Why?
|
| Cell Line | 2 | 2014 | 16263 | 0.050 |
Why?
|
| Immunotherapy | 3 | 2012 | 4257 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 4409 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21591 | 0.050 |
Why?
|
| Palate, Soft | 1 | 2021 | 93 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5236 | 0.050 |
Why?
|
| Antibodies | 1 | 2009 | 2417 | 0.050 |
Why?
|
| Laboratories | 1 | 2005 | 455 | 0.050 |
Why?
|
| Capillaries | 1 | 2004 | 773 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1821 | 0.050 |
Why?
|
| MicroRNAs | 2 | 2014 | 3715 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1907 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7840 | 0.050 |
Why?
|
| Cell Movement | 1 | 2012 | 5287 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2272 | 0.050 |
Why?
|
| Vaccination | 1 | 2012 | 3118 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2004 | 486 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6669 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6227 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2002 | 251 | 0.050 |
Why?
|
| Young Adult | 4 | 2015 | 55781 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2006 | 2614 | 0.040 |
Why?
|
| Hand Strength | 1 | 2022 | 437 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2943 | 0.040 |
Why?
|
| Uncertainty | 1 | 2004 | 699 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2011 | 3615 | 0.040 |
Why?
|
| Proteome | 1 | 2009 | 1767 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1130 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2947 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 1116 | 0.040 |
Why?
|
| Prednisone | 1 | 2004 | 1549 | 0.040 |
Why?
|
| Perforin | 1 | 2019 | 172 | 0.040 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2019 | 92 | 0.040 |
Why?
|
| Prednisolone | 1 | 2020 | 337 | 0.040 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2018 | 46 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2798 | 0.040 |
Why?
|
| Neutropenia | 1 | 2004 | 880 | 0.040 |
Why?
|
| Azathioprine | 1 | 2020 | 352 | 0.040 |
Why?
|
| Gene Library | 1 | 2001 | 1081 | 0.040 |
Why?
|
| Vasculitis | 1 | 2002 | 513 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2760 | 0.040 |
Why?
|
| Granzymes | 1 | 2019 | 270 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2018 | 74206 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4515 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 61761 | 0.040 |
Why?
|
| Hepatitis | 1 | 2019 | 224 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 2860 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2004 | 654 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2022 | 1866 | 0.040 |
Why?
|
| Peptides | 1 | 2009 | 4390 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3460 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5041 | 0.040 |
Why?
|
| Nystagmus, Pathologic | 1 | 1996 | 90 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 400 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2019 | 863 | 0.030 |
Why?
|
| Athetosis | 1 | 1994 | 17 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18033 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3502 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3172 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2022 | 1347 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3389 | 0.030 |
Why?
|
| Algorithms | 2 | 2005 | 13765 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 5544 | 0.030 |
Why?
|
| Facial Nerve | 1 | 1996 | 264 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 1 | 2014 | 26 | 0.030 |
Why?
|
| Chorea | 1 | 1994 | 76 | 0.030 |
Why?
|
| Anemia | 1 | 2004 | 1466 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14721 | 0.030 |
Why?
|
| Mice | 4 | 2014 | 80300 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2020 | 1377 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1996 | 892 | 0.030 |
Why?
|
| Risk | 2 | 2019 | 9700 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1996 | 1313 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2014 | 171 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5934 | 0.030 |
Why?
|
| Haplotypes | 1 | 2020 | 2782 | 0.030 |
Why?
|
| Methotrexate | 1 | 2020 | 1711 | 0.030 |
Why?
|
| Peptide Termination Factors | 1 | 2013 | 58 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2099 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 9022 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 1990 | 0.030 |
Why?
|
| Length of Stay | 1 | 2006 | 6234 | 0.030 |
Why?
|
| Linear Models | 1 | 2002 | 5937 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 559 | 0.030 |
Why?
|
| Meningococcal Vaccines | 1 | 2012 | 98 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2021 | 40440 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2012 | 329 | 0.020 |
Why?
|
| Software | 1 | 2005 | 4406 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1996 | 757 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 34337 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1996 | 1241 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2004 | 3056 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 84401 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 19908 | 0.020 |
Why?
|
| Child | 4 | 2021 | 75163 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 1691 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 13932 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 903 | 0.020 |
Why?
|
| Pain | 1 | 2002 | 4830 | 0.020 |
Why?
|
| Phenotype | 2 | 2003 | 16272 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 2005 | 7561 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18301 | 0.020 |
Why?
|
| Interleukins | 1 | 2011 | 790 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3165 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2011 | 1123 | 0.020 |
Why?
|
| Acute Disease | 1 | 1996 | 7095 | 0.020 |
Why?
|
| Disease Progression | 1 | 2002 | 13157 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 419 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1626 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 588 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3902 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 8918 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2549 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 24985 | 0.020 |
Why?
|
| Exanthema | 1 | 2009 | 481 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 28737 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 677 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2004 | 335 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 10247 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 1747 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2013 | 1949 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7683 | 0.010 |
Why?
|
| RNA | 1 | 2013 | 2718 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 257 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1388 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 14992 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13576 | 0.010 |
Why?
|
| Medicare | 1 | 2018 | 6252 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4430 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 820 | 0.010 |
Why?
|
| Troponin T | 1 | 2004 | 743 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 71009 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 737 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2487 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2004 | 19624 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4999 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2980 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10335 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 3400 | 0.010 |
Why?
|
| Sensation Disorders | 1 | 1994 | 153 | 0.010 |
Why?
|
| Proprioception | 1 | 1994 | 129 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 4809 | 0.010 |
Why?
|
| Regeneration | 1 | 2002 | 1513 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12991 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5215 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2934 | 0.010 |
Why?
|
| United States | 1 | 2018 | 68403 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 14974 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2004 | 6539 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1994 | 1204 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 9669 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12080 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1994 | 2983 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 5698 | 0.000 |
Why?
|